Clinical Trial Update: Treatment of TNNT1-Myopathy With L-Tyrosine. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating L-tyrosine for TNNT1-related nemaline myopathy (nemaline myopathy).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nemaline Myopathy

Drugs mentioned

• L-Tyrosine (L-tyrosine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Nemaline Myopathy | Phase 2 | Status: UNKNOWN